Selective inhibition of interleukin-2 inducible T cell kinase (ITK) enhances anti-tumor immunity in association with Th1-skewing, cytotoxic T cell activation, and reduced T cell exhaustion
L.-Y. Hsu, J. T. Rosenbaum, E. Verner, W. B. Jones, C. M. Hill, J. W. Janc, J. J. Buggy, N. Ding, J. C. Reneau, M. S. Khodadoust, Y. H. Kim, R. A. Wilcox, R. A. Miller
bioRxiv · Jul 5, 2023 · PreprintCancer Biology